Fernando Ramón

Fernando Ramón

Auto-generated profile, based on publicly available information

Fernando Ramón

Department of Biochemistry and Molecular Biology, Faculty of Biology, Complutense University (UCM), José Antonio Novais 12, 28040 Madrid, Spain

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
NDNoton Dutta
Noton Dutta
LKLee G. Klinkenberg
Lee G. Klinkenberg
MVMaria-Jesus Vazquez
Maria-Jesus Vazquez
DSDelfina Segura-Carro
Delfina Segura-Carro
GCGonzalo Colmenarejo
Gonzalo Colmenarejo
PKPetros C. Karakousis
Petros C. Karakousis
The stringent response enzyme is a promising new target for Mycobacterium tuberculosis persisters.

1 December 2002 in SLAS Discovery
Verified
Journal Article
Open access
PDF file
PTPaul B. Taylor
Paul B. Taylor
SAStephen Ashman
Stephen Ashman
SBStuart M. Baddeley
Stuart M. Baddeley
SBStacy L. Bartram
Stacy L. Bartram
CBClive D. Battle
Clive D. Battle
RMRicardo Macarron
Ricardo Macarron
The thrust of early drug discovery in recent years has been toward the configuration of homogeneous miniaturized assays. This has allowed organizations to contain costs in the face of exponential increases in the number of screening assays that need to be run to remain competitive. Miniaturization brings with it an increasing dependence on instrumentation, which over the past several years has seen the development of nanodispensing capability and sophisticated detection strategies. To maintain confidence in the data generated from miniaturized assays, it is critical to ensure that both compounds and reagents have been delivered as expected to the target wells. The authors have developed a standard operating procedure for liquid-handling quality control that has enabled them to evaluate performance on 2 levels. The first level provides for routine daily testing on existing instrumentation, and the second allows for more rigorous testing of new dispensing technologies. The procedure has shown itself to be useful in identifying both method programming and instrumentation performance shortcomings and has provided a means to harmonizing instrumentation usage by assay development and screening groups. The goal is that this type of procedure be used for facilitating the exchange of liquid handler performance data across the industry.

2 March 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
VTValentin Trofimov
Valentin Trofimov
SKSébastien Kicka
Sébastien Kicka
SMSabrina Mucaria
Sabrina Mucaria
NHNabil Hanna
Nabil Hanna
FRFernando Ramon-Olayo
Fernando Ramon-Olayo
TSThierry Soldati
Thierry Soldati
Tuberculosis remains a serious threat to human health world-wide, and improved efficiency of medical treatment requires a better understanding of the pathogenesis and the discovery of new drugs. In the present study, we performed a whole-cell based screen in order to complete the characterization of 168 compounds from the GlaxoSmithKline TB-set. We have established and utilized novel previously unexplored host-model systems to characterize the GSK compounds, i.e. the amoeboid organisms D. discoideum and A. castellanii, as well as a microglial phagocytic cell line, BV2. We infected these host cells with Mycobacterium marinum to monitor and characterize the anti-infective activity of the compounds with quantitative fluorescence measurements and high-content microscopy. In summary, 88.1% of the compounds were confirmed as antibiotics against M. marinum, 11.3% and 4.8% displayed strong anti-infective activity in, respectively, the mammalian and protozoan infection models. Additionally, in the two systems, 13–14% of the compounds displayed pro-infective activity. Our studies underline the relevance of using evolutionarily distant pathogen and host models in order to reveal conserved mechanisms of virulence and defence, respectively, which are potential “universal” targets for intervention. Subsequent mechanism of action studies based on generation of over-expresser M. bovis BCG strains, generation of spontaneous resistant mutants and whole genome sequencing revealed four new molecular targets, including FbpA, MurC, MmpL3 and GlpK.

16 December 2016 in Scientific Reports
Verified
Journal Article
Open access
Jonathan A.G. CoxJonathan A.G. Cox
Jonathan A.G. Cox
GMGrace Mugumbate
Grace Mugumbate
LPLaura Vela-Glez Del Peral
Laura Vela-Glez Del Peral
MJMonika Jankute
Monika Jankute
KAKatherine A. Abrahams
Katherine A. Abrahams
GBGurdyal S. Besra
Gurdyal S. Besra
High-throughput phenotypic screens have re-emerged as screening tools in antibiotic discovery. The advent of such technologies has rapidly accelerated the identification of ‘hit’ compounds. A pre-requisite to medicinal chemistry optimisation programmes required to improve the drug-like properties of a ‘hit’ molecule is identification of its mode of action. Herein, we have combined phenotypic screening with a biased target-specific screen. The inosine monophosphate dehydrogenase (IMPDH) protein GuaB2 has been identified as a drugable target in Mycobacterium tuberculosis, however previously identified compounds lack the desired characteristics necessary for further development into lead-like molecules. This study has identified 7 new chemical series from a high-throughput resistance-based phenotypic screen using Mycobacterium bovis BCG over-expressing GuaB2. Hit compounds were identified in a single shot high-throughput screen, validated by dose response and subjected to further biochemical analysis. The compounds were also assessed using molecular docking experiments, providing a platform for their further optimisation using medicinal chemistry. This work demonstrates the versatility and potential of GuaB2 as an anti-tubercular drug target.

31 August 2000 in Enzyme and Microbial Technology
Verified
Journal Article
Closed access
IMIsabel De La Mata
Isabel De La Mata
FRFernando Ramón
Fernando Ramón
VOVirginia Obregón
Virginia Obregón
MCMa Pilar Castillón
Ma Pilar Castillón
CACarmen Acebal
Carmen Acebal

3 January 2018 in Catalysts
Verified
Journal Article
Open access
PDF file
AFAlba Fresco
Alba Fresco
Jesús Fernández-LucasJesús Fernández-Lucas
Jesús Fernández-Lucas
CACarmen Acebal
Carmen Acebal
MAMiguel Arroyo
Miguel Arroyo
FRFernando Ramón
Fernando Ramón
José M MancheñoJosé M Mancheño
José M Mancheño
Structure-function relationships of a novel 2′-deoxyribosyltransferase from the psychrotolerant bacterium Bacillus psychrosaccharolyticus (BpNDT) have been exhaustively studied by biochemical and high resolution crystallographic analyses. Despite BpNDT exhibiting some structural features characteristic of cold-adapted enzymes such as localized flexibility in critical loops, its biochemical properties are typical of mesophilic enzymes. BpNDT is a highly symmetrical homohexamer with tightly associated subunits that possesses flexible and short loops bordering the active sites. The catalytic center is essentially identical to that of other mesophilic homologues. Moreover, BpNDT shows that it is a mesophilic-like enzyme since it is not heat-labile and exhibits an apparent unfolding temperature (Tm) of 49 °C, being active during 96 h at 40 and 50 °C. Finally, BpNDT synthesizes natural and modified nucleosides, with preference for purines as acceptors and pyrimidine nucleosides as donors. Remarkably, the synthesis of several therapeutic nucleosides has been efficiently carried out. In this sense, 5-hydroxymethyl-2′-deoxyuridine (5-HMdUrd), 7-deaza-6-hydroxypurine-2′-deoxyriboside (7-DHPdRib) and theophylline-2′-deoxyriboside were synthesized for the first time by an NDT enzyme, showing the biotechnological interest of BpNDT.